17. Postponed judgment

The Board shall consider whether judgment shall be postponed.

Where judgment has been postponed, the hearing shall be adjourned to a date to be determined by the Board.

The notice of the date on which the hearing is to continue shall be given to the Board’s representative and the pharmacist under inquiry not less than 4 weeks before that date.

The pharmacist under inquiry shall be asked to submit to the Board, not later than 3 weeks before the hearing, any statement or testimonial regarding his conduct or the name and address of any person to whom reference may be made as to his character.

A copy of the statement or testimonial shall be sent to the complainant.

At the resumed hearing any other fact may be brought to the attention of the Board if it relates to the matter under inquiry.

The Board’s representative shall recall the stage at which the proceedings were adjourned and the Board may —

hear any other submission by the Board’s representative or the pharmacist under inquiry; and

receive such further evidence in relation to the case or to the conduct of the pharmacist since the adjournment as it thinks fit.

The Board shall then determine whether it should further postpone its judgment.

The Board shall consider whether judgment shall be postponed.

Where judgment has been postponed, the hearing shall be adjourned to a date to be determined by the Board.

The notice of the date on which the hearing is to continue shall be given to the Board’s representative and the pharmacist under inquiry not less than 4 weeks before that date.

The pharmacist under inquiry shall be asked to submit to the Board, not later than 3 weeks before the hearing, any statement or testimonial regarding his conduct or the name and address of any person to whom reference may be made as to his character.

A copy of the statement or testimonial shall be sent to the complainant.

At the resumed hearing any other fact may be brought to the attention of the Board if it relates to the matter under inquiry.

The Board’s representative shall recall the stage at which the proceedings were adjourned and the Board may —

hear any other submission by the Board’s representative or the pharmacist under inquiry; and

receive such further evidence in relation to the case or to the conduct of the pharmacist since the adjournment as it thinks fit.

The Board shall then determine whether it should further postpone its judgment.